Drugs News and Research

RSS

Liquid biopsies provide complete picture of genetic alterations linked to cancer drug resistance

Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.

10 Sep 2019

Scientists develop new method to test for drug-resistant infections

Scientists have developed a method to test whether an infection is resistant to common antibiotics.

10 Sep 2019

Lung-MAP study: Majority of cancer patients don't understand genomic test results

A majority of cancer patients don't understand key aspects of the genomic test results they receive as participants in biomarker-driven clinical trials, according to a first-of-its-kind pilot study conducted under the Lung Cancer Master Protocol.

10 Sep 2019

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

10 Sep 2019

Early antibiotic exposure causes long-lasting collateral damage in premature babies

Nearly all premature babies receive antibiotics in their first weeks of life to ward off or treat potentially deadly bacterial infections.

9 Sep 2019

Researchers investigate how to prevent the onset of schizophrenia using mouse model

Although predisposing processes occur earlier, schizophrenia breaks out at young adulthood, suggesting it might involve a pathological transition during late brain development in predisposed individuals.

9 Sep 2019

Researchers develop new cocktail of drugs that shrink pancreatic tumors

Cancer is relentless and resilient. When a drug blocks a cancer cell's main survival pathway, the cell avoids the obstacle by taking different pathways or detours to save itself. This tactic is called "developing resistance," and it's one of the key challenges researchers face when seeking effective therapeutics to combat pancreatic ductal adenocarcinoma (PDA).

9 Sep 2019

Study looks at effects of Ritalin on children with ADHD

When children with ADHD don't respond well to Methylphenidate (MPH, also known as Ritalin) doctors often increase the dose.

9 Sep 2019

Malaria could be completely eradicated by 2050

A new report published on the 8th of September 2019 by The Lancet Commission says that mosquito-borne malaria that kills thousands across the world could be eradicated by 2050. A team of 41 researchers including those that are experts on malaria, scientists, health policy experts as well as economists came together to create this exhaustive report on current status of malaria and its future around the world.

9 Sep 2019

Enzyme in plants key to developing novel pharmaceuticals

Plants have many superpowers, such as manufacturing compounds to help repel pests, protecting themselves from environmental hazards, and providing a plethora of essential oils and other compounds that can heal a multitude of infections and other diseases.

9 Sep 2019

Study offers hope for people suffering from chronic pain

When you experience severe pain, like breaking or shattering a bone, the pain isn't just felt at the sight of the injury.

9 Sep 2019

Chronic hypertension among older pregnant women has spiked by more than 75% since 1970

The rate of chronic hypertension among pregnant women age 35 and over in the United States has increased by more than 75% since 1970, with black women suffering from persistent high blood pressure at more than twice the rate of white women, according to a Rutgers study.

9 Sep 2019

Eradicating malaria by 2050 would be 'an achievement of historic proportions', say experts

According to a major report by 41 leading scientists, health-policy experts and economists, the world could be free of malaria by 2050.

9 Sep 2019

Millions of diabetes patients are missing out on Medicare’s nutrition help

Louis Rocco has lived with diabetes for decades but, until he met with a registered dietitian in August, he didn't know eating too much bread was dangerous for him.

9 Sep 2019

Rutgers study finds genetically tractable cause of drug-tolerant tuberculosis

A Rutgers New Jersey Medical School study has found a genetically tractable cause of drug tolerant tuberculosis, paving the way for researchers to develop new drugs to combat the global TB epidemic and cure the disease.

9 Sep 2019

Drug tolerant Tuberculosis could soon be tracked using genes

A team of researchers from the Rutgers New Jersey Medical School have found genetic foot prints of tuberculosis bacteria that are resistant to the commonly used anti-tubercular drugs. This could help scientists develop drugs to combat drug resistance in tuberculosis.

8 Sep 2019

Age affects efficacy of immunotherapy treatment for breast cancer, preclinical study reveals

Recent clinical trials have indicated that immune checkpoint blockade (ICB) therapy, which is designed to unleash a patient's immune system to attack cancer, has been revolutionary in its implications for breast cancer treatment, especially for its potential to treat patients with triple negative breast cancer.

8 Sep 2019

Key plant enzyme could pave way for development of medications and other products

Plants can do many amazing things. Among their talents, they can manufacture compounds that help them repel pests, attract pollinators, cure infections and protect themselves from excess temperatures, drought and other hazards in the environment.

8 Sep 2019

Tiny fat bubbles hold key to rebooting the immune system and calming disease process

People living with inflammatory autoimmune disease could benefit from an 'immune system reboot', and researchers have isolated specific cells to target.

7 Sep 2019

FDA approves first drug to treat patients with rare lung condition

The U.S. Food and Drug Administration today approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or scleroderma, called SSc-ILD. It is the first FDA-approved treatment for this rare lung condition.

7 Sep 2019

Drugs News and Research

Liquid biopsies provide complete picture of genetic alterations linked to cancer drug resistance

Scientists develop new method to test for drug-resistant infections

Lung-MAP study: Majority of cancer patients don't understand genomic test results

NIAID experts call for innovative research on STIs

Early antibiotic exposure causes long-lasting collateral damage in premature babies

Researchers investigate how to prevent the onset of schizophrenia using mouse model

Researchers develop new cocktail of drugs that shrink pancreatic tumors

Study looks at effects of Ritalin on children with ADHD

Malaria could be completely eradicated by 2050

Enzyme in plants key to developing novel pharmaceuticals

Study offers hope for people suffering from chronic pain

Chronic hypertension among older pregnant women has spiked by more than 75% since 1970

Eradicating malaria by 2050 would be 'an achievement of historic proportions', say experts

Millions of diabetes patients are missing out on Medicare’s nutrition help

Rutgers study finds genetically tractable cause of drug-tolerant tuberculosis

Drug tolerant Tuberculosis could soon be tracked using genes

Age affects efficacy of immunotherapy treatment for breast cancer, preclinical study reveals

Key plant enzyme could pave way for development of medications and other products

Tiny fat bubbles hold key to rebooting the immune system and calming disease process

FDA approves first drug to treat patients with rare lung condition

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News